Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue.
Jankowski W, McGill J, Lagassé HAD, Surov S, Bembridge G, Bunce C, Cloake E, Fogg MH, Jankowska KI, Khan A, Marcotrigiano J, Ovanesov MV, Sauna ZE.
Jankowski W, et al. Among authors: lagasse had.
Blood Adv. 2019 Sep 10;3(17):2668-2678. doi: 10.1182/bloodadvances.2019000338.
Blood Adv. 2019.
PMID: 31506285
Free PMC article.